Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 27: 318-321, 1981;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Derks, H. J.
Right arrow Articles by Koedam, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Derks, H. J.
Right arrow Articles by Koedam, J. C.

Clinical Chemistry, Vol 27, 318-321, Copyright © 1981 by American Association for Clinical Chemistry

Elimination of inhibitors of alkaline phosphatase from 2-amino-2-methyl- 1-propanol

HJ Derks, V Borrias-van Tongeren, JB Terlingen and JC Koedam

When 2-amino-2-methyl-1-propanol buffer solutions are extracted with chloroform, impurities inhibiting alkaline phosphatase are selectively removed and this source of variation is thereby greatly decreased. We also studied the effect of adding zinc sulfate to this buffer. A combination of chloroform extraction and zinc sulfate, added to give concentrations from 5 to 10 mumol/L, results in buffer of high and consistent quality. The alkaline phosphatase activities of 12 reference sera of different origin were determined with use of the purified buffers. Those sera, which closely resembled human serum in terms of alkaline phosphatase isoenzyme composition, behaved similarly to human serum. Use of such control sera is strongly recommended.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American Association for Clinical Chemistry.